ONCODES.PREC.MED. EO-34 (ZR8) — Defensive Interval Ratio
ONCODES.PREC.MED. EO-34 (ZR8) has a Defensive Interval Ratio of 553 days as of December 2024. Defensive assets of €5.46 Million (cash €-, short-term investments €4.84 Million, receivables €624.20K) cover 553 days of daily cash needs of €9.88K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ONCODES.PREC.MED. EO-34 Defensive Interval Ratio (2021–2024)
This chart shows how ONCODES.PREC.MED. EO-34's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of December 2024, the ratio stands at 553 days, meaning defensive assets of €5.46 Million can fund 553 days of operations without new revenue. For the complete balance sheet picture, see ZR8 total assets.
Annual Defensive Interval Ratio for ONCODES.PREC.MED. EO-34 (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for ONCODES.PREC.MED. EO-34 from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See ONCODES.PREC.MED. EO-34 short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 553 days | €5.46 Million | €9.88K/day | €- | €4.84 Million | ▼ -430 days |
| 2023 | 983 days | €11.08 Million | €11.27K/day | €- | €10.01 Million | ▲ +927 days |
| 2022 | 56 days | €606.50K | €10.86K/day | €- | €125.00K | ▼ -51 days |
| 2021 | 107 days | €354.85K | €3.31K/day | €- | €- | — |